ICON: DIA Live to Provide a Digital Window into DIA Conference 2016
23 Juin 2016 - 9:00AM
Business Wire
Social media aggregation site will highlight
digital conversation hotspots and help amplify thought leadership
and debate at DIA 2016
ICON plc, (NASDAQ: ICLR) a global provider of drug
development solutions and services to the pharmaceutical,
biotechnology and medical device industries, today announced that
it will be presenting DIA Live – a social media aggregation site
that allows visitors to track and analyse Twitter conversations
from delegates at the DIA2016 Global Annual Meeting (26-30 June,
Philadelphia, PA).
The platform will provide a single source for visitors to view
the social media conversations from participants at the DIA 2016,
alongside broader conversations from Twitter users around the world
using the hashtag #DIA2016.
This is a new collaboration between ICON and DIA, and the first
time such an innovative data analysis and visualisation platform is
being used to measure audience engagement and track social and
digital media conversations around the event. The site is set to go
live on the first day of the conference (26th June) and will
aggregate and stream a live feed of tweets sent by conference
delegates as well as other participants.
DIA Live presents a convenient source for visitors to view key
or trending topics, real time discussions, as well as stats and
interactive infographics measuring activity and influence. Visitors
to the platform will also be able to apply filters to tune into
specific topics, compare discussions from previous days and have
the opportunity to participate and shape debate.
This year the DIA 2016 conference is set to attract thousands of
delegates from around the world who will be examining a wide range
of topics from big data and cyber security to patient engagement
and health care regulation. Using powerful data analysis in this
context is a valuable opportunity for participants to follow
specific areas of interest in an otherwise complex and vast
dialogue space by applying filters or tracking relevant
hashtags.
Those with an interest in the DIA2016 event but are unable to
attend will have the opportunity to participate in live
conversations via the platform as well.
David Green, VP Marketing, ICON said “We are excited to be
collaborating with the DIA in the launch of this innovative digital
platform. The DIA Annual Meeting centres around fostering
innovation and cross-discipline integration, so it is fitting that
this year the launch of this platform will enable individuals
around the world to participate in these discussions.”
“The conversations at DIA 2016 will cover the most pressing
issues facing the life sciences industry today,” Jonathan Commons,
Senior Vice President of Marketing commented. “DIA Live will
provide valuable insight and analysis to navigate the conversations
from the world’s largest gathering of life science industry
professionals.”
To participate in this year’s conference, follow and engage with
our team via www.dialive.org
About DIA 2016
DIA 2016 is DIA’s global annual meeting to advance health care
product development around the world by connecting stakeholders to
interdisciplinary insights and innovation. As the organization’s
largest interdisciplinary event, DIA 2016 is a gathering of global
perspectives bringing together a network of more than 7,000
professionals to foster innovation that leads to the development of
safe and effective products and therapies to patients. The global
annual meeting will draw attendees from 51 countries for the
five-day conference, which also features a three-day expo with more
than 450 exhibitors. For more information visit
www.DIAglobal.org/DIA2016 or follow DIA on Twitter, LinkedIn, and
Facebook. Join the conversation using #DIA2016.
About ICON plc
ICON plc is a global provider of drug development solutions and
services to the pharmaceutical, biotechnology and medical device
industries. The company specialises in the strategic development,
management and analysis of programs that support clinical
development - from compound selection to Phase I-IV clinical
studies. With headquarters in Dublin, Ireland, ICON currently,
operates from 89 locations in 37 countries and has approximately
12,200 employees.
Further information is available at www.iconplc.com
ICON/ICLR-G
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and
industry conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, as well as
economic and global market conditions and other risks and
uncertainties detailed from time to time in SEC reports filed by
ICON, all of which are difficult to predict and some of which are
beyond our control. For these reasons, you should not place undue
reliance on these forward-looking statements when making investment
decisions. The word "expected" and variations of such words and
similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they
are made and we do not undertake any obligation to update publicly
any forward-looking statement, either as a result of new
information, future events or otherwise. More information about the
risks and uncertainties relating to these forward-looking
statements may be found in SEC reports filed by ICON, including its
Form 20-F, F-1, S-8 and F-3, which are available on the SEC's
website at http://www.sec.gov.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160623005357/en/
ICON Media ContactCamille FrederixWeber Shandwick+44 (0)
207 067 0272cfrederix@webershandwick.com
ICON (NASDAQ:ICLR)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024
ICON (NASDAQ:ICLR)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024